Advice notices

They are equivalent to the MDA 'immediate action' category. They remain valid unless they are updated or withdrawn. They are reviewed once they are five years old (and subsequently every five years) and the lists on this website are amended accordingly.

Latest advice notices

• 01 Nov 1999| AN 1999(06) Thromboembolic complications involving Silzone mechanical heart valves

  High rate of early thromboembolic complications associated with St Jude Medical's Silzone® (silver coated) mechanical heart valve, particularly among mitral valve patients.

• 01 Nov 1999| AN 1999(05) Abbott in vitro diagnostic products: Additional precautions for use

  As a result of apparent failures to comply with local good manufacturing practice requirements at the Abbott Lake County manufacturing site in the USA, adoption of additional quality control measures is recommended with in vitro diagnostic medical devices (IVDs) manufactured at this site.

• 01 Oct 1999| AN 1999(04) Single patient use of ophthalmic medical devices: implications for clinical practice

  Implementation of advice on the use of ophthalmic medical devices that touch the surface of the eye from the Spongiform Encephalopathy Advisory Committee (SEAC).

• 01 Oct 1999| AN 1999(03) Single patient use of contact lenses: implications for clinical practice

  Implementation of additional advice on the use of contact lenses from Spongiform Encephalopathy Advisory Committee (SEAC).

• 08 Mar 1999| AN 1999(01) Trilucent™ breast implants: Voluntary recall

  Voluntary recall of Trilucent™ breast implants because of
  concerns about long term safety.